GREENE MARK I has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NISHIDA TERUO, Pierre Fabre Médicament and BIOCELLS BEIJING BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Electrotherapy | |
#7 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Greene Mark I | 19 |
#2 | Murali Ramachandran | 13 |
#3 | Zhang Hongtao | 9 |
#4 | Berezov Alan | 4 |
#5 | O'Rourke Donald M | 4 |
#6 | Park Byeong Woo | 3 |
#7 | Liu Qingdu | 2 |
#8 | Chen Jinqiu | 2 |
#9 | Richter Mark | 2 |
#10 | Xiao Yan | 2 |
Publication | Filing date | Title |
---|---|---|
WO2011115763A1 | Inhibitors of the tumor necrosis factor receptor complex | |
US2013052194A1 | Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same | |
US2012164066A1 | Antigen-binding proteins comprising recombinant protein scaffolds |